Diabetes Care 29, 15541559 (2006)
This content is provided for educational purposes and does not guarantee outcomes or replace a personalized medical evaluation
So it can cause organ damage and peripheral neuropathy, diabetic retinopathy
Retatrutide is investigated as a unimolecular agonist that engages three complementary incretin and glucagon pathways simultaneously, with research interest in body composition, hepatic lipid metabolism, glycemic endpoints, and energy expenditure in obesity and metabolic disease models
However, based on mechanistic understanding and data from similar medications, theres no evidence of permanent metabolic impairment
Emerging evidence highlights taste and olfactory disturbances as underrecognized NAEs of GLP-1 RA therapy 44,45,46